Quality of Life Before and After Liver Transplantation for Cholestatic Liver Disease
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Liver transplantation (LT) is an established therapy for patients with end–stage primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). In this report, we describe the health status and quality of life (QOL) in patients with these cholestatic liver diseases before and after LT. A QOL questionnaire was completed by 157 adult patients with PBC or PSC before and 1 year after liver transplantation at the Mayo Clinic or Baylor University Medical Center. This questionnaire measured four aspects of QOL, including symptoms; physical, social, and emotional functioning; health perceptions; and overall QOL. Changes in these QOL parameters before and after LT were described, and regression analysis was used to assess the relationships between clinical and QOL factors. There were no differences in QOL parameters between patients with PBC and PSC. QOL following transplantation was substantially better than before transplantation. This was observed in all four aspects of QOL. The degree of improvement as measured by effect size (difference in mean scores divided by the pretransplantation standard deviation) was 0.53 for symptoms (P<.01), 1.16 for function (P < .01), 2.37 for health satisfaction (P < .01), and 1.16 for overall QOL (P< .01). Patients' overall QOL before transplantation was significantly related to subjective and objective health status indicators and clinical factors such as ascites and renal dysfunction. QOL at 1–year follow–up, however, could not be adequately predicted by the pretransplantation subjective health status and clinical factors. Patients with end–stage cholestatic disease undergoing LT experience substantial improvement in all aspects of QOL addressed in this study. The patients' QOL 1 year after LT could not be predicted by pretransplantation variables used in this study
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liver transplantation for cholestatic pruritus is highly effective in terms of rapid reduction in pruritus severity (frequently within the first 24 h of transplantation) [212].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [212]
In the citing paper
“Liver transplantation for cholestatic pruritus is highly effective in terms of rapid reduction in pruritus severity (frequently within the first 24 hours of transplantation).204”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [204]
Citations
Cites
Diener, E. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.95.3.542 · Cited by 11,023
Diener, E. (2009) · Social Indicators Research Series · doi:10.1007/978-90-481-2350-6_2 · Cited by 10,950
Взаимосвязь статуса занятости и пола с уровнем психологического благополучия
М.Р., Н., & С.И., Б. (2026) · Cifra LLC Journals · doi:10.60797/irj.2026.170.43 · Cited by 7,950
Multiple comparisons among means
Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006
The Structure of Psychological Well-Being.
Mechanic, D., & Bradburn, N. M. (1970) · American Sociological Review · doi:10.2307/2093340 · Cited by 4,923
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Motamedi, K. K., Campbell, A., Converse, P. E., & Rodgers, W. L. (1977) · The Academy of Management Review · doi:10.2307/257525 · Cited by 1,954
Research works printed but not linked: 4
- Price, 1995, J Royal Soc Med, 88, 130
- Hunt, 1985, J R Coll Gen Pract, 35, 185
- Statistical Power Analysis for the Behavorial Sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates. 1988;8-17.
- Adams, 1995, Hepatology, 21, 140
Cited by
Items 101–192 of 192
Liver Transplantation for Patients with Cholestatic Liver Diseases
Schöning, W., Schmeding, M., Ulmer, T. F., Andert, A., & Neumann, U. P. (2015) · Visceral Medicine · doi:10.1159/000431017 · Cited by 20
Hepatic Encephalopathy: A Dynamic or Static Condition
Stewart, C. A., & Cerhan, J. (2005) · Metabolic Brain Disease · doi:10.1007/s11011-005-7207-x · Cited by 19
“quality of life (Gross et al., 1999; Karam et al., 2003; Moore et al., 2000; O’Carroll et al., 2003; Ratcliffe et al., 2002) in patients with decompensated cirrhosis.”
BackgroundEstimation and comparison of derived preference scores from the SF-36 in lung transplant patients
Lobo, F. S., Gross, C. R., & Matthees, B. J. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018488.95206.d6 · Cited by 16
“Cronbach’s a reliability of the liver transplant version of this scale was 0.81–0.85 [ 40 ].”
BackgroundInfluentialSelf-citationRimmer, B., Jenkins, R., Russell, S., Craig, D., Sharp, L., & Exley, C. (2024) · Transplantation Reviews · doi:10.1016/j.trre.2024.100836 · Cited by 22
Primary biliary cirrhosis and liver transplantation
Akamatsu (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.2.66 · Cited by 26
Jin, S., Xiang, B., Zhong, L., Yan, L.-N., Chen, Z., Wang, W., Xu, M. Q., & Yang, J. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.05.076 · Cited by 14
Liver transplantation in chronic cholestatic conditions
Milkiewicz, P., Wunsch, E., & Elias, E. (2011) · Frontiers in bioscience · doi:10.2741/3966 · Cited by 14
“Chronic fatigue is frequently associated with PBC (8) and exerts a significant effect on the patient’s quality of life, generating profound disability and distress, often out of proportion to the patient`s physical status (9).”
BackgroundBarriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise
Corrigan, M., Hirschfield, G. M., Greenfield, S., & Parry, J. M. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000226 · Cited by 12
Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review
McKay, K., Walmsley, M., Senior, R., Thorburn, D., Kennedy, E., & Ranieri, V. F. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1676099 · Cited by 14
Mawardi, M., Alalwan, A. M., Fallatah, H. I., Abaalkhail, F. A., Hasosah, M. Y., Shagrani, M. A., Alghamdi, M., & Alghamdi, A. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_112_21 · Cited by 14
“[196] Invasive procedures such as bile duct drainage, plasmapheresis, and extracorporeal albumin dialysis have been reported with some efficacy in several case reports[197‐200] Recipients of LT are likely to experience relief from pruritus related to cholestasis.[201]”
BackgroundMedical Aspects of Liver Transplantation
Wiesner, R. H. (2002) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(02)70034-1 · Cited by 12
Self-citationManagement of Fatigue in Primary Biliary Cholangitis
Khanna, A., Hegade, V. S., & Jones, D. E. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00458-0 · Cited by 11
Krawczyk, M. J., Koźma, M., Szymańska, A., Leszko, K., Przedniczek, M., Mucha, K., Foroncewicz, B., Pączek, L., Moszczuk, B., Milkiewicz, P., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13434 · Cited by 12
Beyond Survival: Targeting Health‐Related Quality of Life Outcomes After Liver Transplantation
Cristin, D. J., Forman, L., & Jackson, W. E. (2021) · Clinical Liver Disease · doi:10.1002/cld.1059 · Cited by 13
Patterson, C. F., So, S., DeAngelis, M., Ghent, E., Southmayd, D., & Carpenter, C. (2018) · Pediatric Transplantation · doi:10.1111/petr.13179 · Cited by 10
Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis
Dervout, C., Boulais, N., Barnetche, T., Nousbaum, J., Brenaut, E., & Misery, L. (2022) · Acta Dermato Venereologica · doi:10.2340/actadv.v102.310 · Cited by 13
“Pruritus seems to be rapidly controlled after surgery, with a major improvement in quality of life (118).”
BackgroundNeuropsychological Aspects of Liver Disease and its Treatment
O’Carroll, R. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9522-7 · Cited by 12
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments
Gabrielli, F., Crepaldi, E., Cavicchioli, A., Rivi, M., Costanzo, A. A. C., Cursaro, C., & Andreoné, P. (2024) · Biomolecules · doi:10.3390/biom14101227 · Cited by 12
“In a comparative study of 157 patients with end-stage PBC or PSC who underwent liver transplantation, itching was significantly reduced after liver transplantation [110].”
Backgroundn, A. O. ⁄. A. ⁄., Marín, J. A. M., pez, M. U. ⁄., Méndez, V. C. B., nez, E. A. ⁄. ‐. ⁄., Ribas‐Aparicio, R. M., Uribe-Noguéz, L. A., guez‐Galindo, D. R. ⁄., & guez, M. ⁄. A. M. ⁄. N. ⁄. (2017) · Biomedical Reports · doi:10.3892/br.2017.1012 · Cited by 9
“Generally, the HR-QoL of patients with CHC deteriorates over the course of the infection (33,34).”
Primary Biliary Cholangitis Guidance Update: Implications for Liver Transplantation
Levy, C. (2018) · Liver Transplantation · doi:10.1002/lt.25321 · Cited by 9
“Fortunately, pruritus had the greatest improvement after LT and was largely eliminated.(24)”
BackgroundResultQuality of Life in Recipients before and after Liver Transplantation in Turkey
Ordin, Y. S., Dicle, A., & Wellard, S. J. (2011) · Progress in Transplantation · doi:10.1177/152692481102100312 · Cited by 10
Chronic Rejection of the Liver
Garcia, R. F. L., Garcia, C. E., & McMaster, P. (2000) · BioDrugs · doi:10.2165/00063030-200014050-00002 · Cited by 9
“,[91] analysing 157 cholestatic patients, showed statistically significant improvement by 1 year in quality of life after liver grafting.”
BackgroundMedical and economic impact of autoimmune hepatitis
Talwalkar, J. A., & Kim, W. R. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00030-2 · Cited by 10
Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging Therapies
Kode, V., & Yimam, K. K. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00638-7 · Cited by 11
Quality of Life in Liver Cirrhosis
Kalaitzakis, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_131 · Cited by 13
Primary biliary cirrhosis: safety and benefits of established and emerging therapies
Tabibian, J. H., & Lindor, K. D. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1073260 · Cited by 9
“treatment among those who are deemed acceptable candidates, it carries substantial costs as well as a risk of PBC recurrence (~ 3% per year), among other short- and long-term potential complications [6,7].”
BackgroundLiver Transplantation for Primary Biliary Cirrhosis
Genda, T., & Ichida, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_21 · Cited by 8
“examined the results of liver transplantations occurring as a result of QOL issues in 157 patients with PBC or primary sclerosing cholangitis [45].”
BackgroundHutson, D. G., Russell, E., Levi, J. U., Jeffers, L. J., Reddy, K. R., Yrizarry, J. M., Scagnelli, T., Sleeman, D., Schiff, E. R., & Livingstone, A. S. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0104-6 · Cited by 8
Fatigue and related factors after liver transplantation
Hong, K., Kim, H., Lee, J., Lee, K., Yi, N., Lee, H. W., Choi, Y., Suh, S., Hong, S. K., Yoon, K. C., et al. (2015) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2015.19.4.149 · Cited by 7
Care of the Cholestatic Patient
Gossard, A. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.11.005 · Cited by 11
“It is nearly as prevalent in patients with PSC or drug-induced cholestasis.(50,54,55) For many with cholestasis, it is identified as the most problematic symptom.”
BackgroundMolski, C., Mattiello, R., Sarria, E. E., Saab, S., Medeiros, R., & Brandão, A. B. D. M. (2016) · Annals of Hepatology · doi:10.5604/16652681.1198810 · Cited by 5
Retorno ao trabalho de pacientes adultos submetidos a transplante de fígado
Parolin, M. B., Coelho, J. C. U., Costa, P. B., Pimentel, S. K., dos SANTOS-NETO, L. E., & Vayego, S. A. (2001) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032001000300006 · Cited by 6
Pretransplant variables associated with quality of life in liver transplant recipients
Saab, S., Ibrahim, A. B., Surti, B., Durazo, F. A., Han, S., Yersiz, H., Farmer, D. G., Ghobrial, R. M., Goldstein, L. I., Tong, M. J., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01831.x · Cited by 6
“For instance, our cohort with 308 recipients is larger than most prior studies that tend to have cohorts of o 140 recipients (24, 25).”
BackgroundResultInfluentialQuality of life instruments for liver transplant recipients: Too many choices?
Kim, W. R. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.19026 · Cited by 6
Szepietowski, J. C., & Reich, A. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_125 · Cited by 6
Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders
Samarasena, J., & Hu, K. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.09.003 · Cited by 5
The timing of liver transplantation in primary biliary cirrhosis
Angulo, P., & Dickson, E. R. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0110 · Cited by 6
Physical Activity and Lifestyle of the Elderly
Drohomirecka, A., Kotarska, K., & Makris, M. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Wang, S., Dong, V., Montaño‐Loza, A. J., & Mason, A. L. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.163 · Cited by 6
Determining the nature and impact of fatigue after liver transplantation
Talwalkar, J. A. (2006) · Liver Transplantation · doi:10.1002/lt.20781 · Cited by 4
“Among patients undergoing LT for cholestatic liver disease, the presence of significant fatigue was commonly observed among recipients for up to 1 year after LT.(9) Similar findings were noted from a multicenter database report”
BackgroundInfluentialLombardi, A. C., Mente, Ê. D., Sankarankutty, A. K., Souza, F. F., Teixeira, A. C., Cagnolati, D., Souza, M. E. J., & Silva, O. D. C. E. (2011) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502011000600020 · Cited by 4
Lebensqualität nach Organtransplantation
Schulz, K., Kraft, S., Ewers, H., Wein, C., Kröncke, S., & Koch, U. (2002) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-002-0482-4 · Cited by 4
“…(LTX) Autor/Jahr Stichprobe Monate Untersuchte Art der Bereiche der Lebensqualität nach TX Patientengruppe Studie Körperlich Psychisch Sozial Gross et al. 1999 [5] n=157 12 PBC oder PSC QS ↑ ↑ ↑ Schulz et al. 1999 [6] n=22 19 ÄTC vs. QS ↑ → ↑ n=22 non-ÄTC Singh et al. 1999 [7] n=14 6, 12…”
InfluentialTransplantation for Primary Biliary Cirrhosis
Imam, M. H., & Talwalkar, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-0268-8.00013-0 · Cited by 4
The Indications and Implications of Liver Transplantation
Simpson, K. J., & Garden, O. J. (1999) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/147827159902900211 · Cited by 4
Primary biliary cirrhosis: lessons learned from an organic-specific disease
Nishio, A., Keeffe, E. B., & Gershwin, M. E. (2001) · Clinical and Experimental Medicine · doi:10.1007/s102380100000 · Cited by 4
Primary Sclerosing Cholangitis
Broomé, U., & Bergquist, A. M. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50047-4 · Cited by 4
Primary and Secondary Sclerosing Cholangitis
Bowlus, C. L., Assis, D. N., & Goldberg, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00043-4 · Cited by 3
Martins, E. B., & Chapman, R. W. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199909000-00011 · Cited by 3
Liver Transplantation: Prevention and Treatment of Rejection
Cecilioni, L., Dagher, L., & Burroughs, A. K. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch36 · Cited by 3
Saad, Z. M., El-Dahrouty, A. H., Elsayed, A. M., Keryakos, H. K. H., Fanous, N. N., & Ibrahim, M. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00025-z · Cited by 2
“Liver cirrhosis severity was determined using Child-Pugh class and MELD score [8].”
MethodHealth-related quality of life and symptoms in autoimmune liver diseases
Janik, M. K., Wunsch, E., & Milkiewicz, P. (2023) · Minerva Gastroenterology · doi:10.23736/s2724-5895.20.02792-0 · Cited by 3
Harnois, D. M., Yataco, M. L., & Nakhleh, R. E. (2014) · Clinical Liver Disease · doi:10.1002/cld.341 · Cited by 3
“Autoimmune liver diseases account for approximately one quarter of all liver transplantations performed in Europe and the United States.1 Although these patients have an excellent survival rate, autoimmune liver disease can recur after LT.”
ResultInfluentialPsychological aspects of liver disease and its treatment
O’Carroll, R. E. (2011) · Health Psychology Review · doi:10.1080/17437199.2010.550205 · Cited by 2
“Accordingly there has been an increasing emphasis on evaluating psychological and social consequences in recipients, e.g., quality of life and cognitive functioning, as key outcomes (e.g., Gross et al., 1999; Hellgren et al., 1998; Tarter, Switala, Arria, Plail, & Vanthiel, 1991).”
BackgroundQuality of Life and Physical Activity after Liver Transplantation. Literature Review.
Stępień–Słodkowska, M., Niewiadomska, M., & Kotarska, K. (2017) · Central European Journal of Sport Sciences and Medicine · doi:10.18276/cej.2017.1-06 · Cited by 2
Quality of Life in Hepatic Encephalopathy
Price, J. K., & Younossi, Z. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-836-8_18 · Cited by 2
Autoimmunassoziierte Gallenwegserkrankungen: Diagnostische und therapeutische Herausforderungen
Herta, T., & Beuers, U. H. (2019) · Der Radiologe · doi:10.1007/s00117-019-0513-x · Cited by 2
Selection and Evaluation of the Recipient (including Retransplantation)
Rockey, D. C. (2006) · doi:10.1002/9780470751541.ch1 · Cited by 2
Jorgensen, R. A. (2010) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 3
Liver Transplantation: Prevention and Treatment of Rejection
Pleguezuelo, M., Germani, G., & Burroughs, A. K. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch42 · Cited by 2
Brown, K., & Moonka, D. (2000) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200005000-00013 · Cited by 2
Primary sclerosing cholangitis and IgG4-associated cholangitis
Bowlus, C. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00020-5 · Cited by 1
MELD: Which Patients Fall Through the Cracks?
Deising, A. C., & Satoskar, R. S. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0211-0 · Cited by 1
Siriwardana, R. C., Jayatunge, D. S. P., Ekanayake, C. S., Tillakaratne, S. B., Niriella, M. A., Gunathilake, B., & Dassanayake, A. S. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00055-7 · Cited by 1
Primary Sclerosing Cholangitis
Geonzon-Gonzales, M. R. (2008) · Gastroenterology Nursing · doi:10.1097/01.sga.0000317086.16924.f1 · Cited by 1
Primary Sclerosing Cholangitis
Sangha, S., & Bowlus, C. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-285-8_56 · Cited by 1
Shinji, I. R. I. E. (2017) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.29.9 · Cited by 1
Primary Sclerosing Cholangitis
Bowlus, C. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_25 · Cited by 1
Primary Sclerosing Cholangitis
Geonzon-Gonzales, M. R. (2007) · Gastroenterology Nursing · doi:10.1097/01.sga.0000267929.62298.64 · Cited by 1
Liver Transplantation and Quality of Life
Navasa, M., & Rodés, J. (2007) · doi:10.1002/9780470691861.ch25g · Cited by 1
Martins, E. B., & Chapman, R. W. (2000) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200009000-00010 · Cited by 1
Health Status Assessment and Economic Analyses in Cirrhosis and Portal Hypertension
Talwalkar, J. A., & Kim, W. R. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-885-4_28
“Short-term improvements in health status following liver transplantation have also been observed in adults with cholestatic liver disease ( 44 ).”
BackgroundPatient Selection and Indications for Liver Transplantation
Brown, K., & Kazimi, M. M. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch29
Casanovas, T., Carmen, M., & Rodrguez, E. (2012) · InTech eBooks · doi:10.5772/29195
Fatigue after Liver Transplantation
van Ginneken, B. T. J. (2009)
Claessen, L. Ó. E. (2013)
Pancreatic Transplantation/Intervention
Sollinger, H. W. (2002) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(02)70032-8
Tian, H. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Caso clinico: una mujer de 65 años, con prurito y astenia
Fajardo, A. (2003) · Salus Journal of Health Sciences
Cirrosis Biliar Primaria en una mujer de 65 años con prurito y astenia. A propósito de un caso
Fajardo, A., Colombet, M., & Mejías, M. T. P. A. (2003)
Liver Transplantation for Primary Biliary Cirrhosis
Talwalkar, J. A., Kim, W. R., & Dickson, E. R. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0118-2.50017-3
Conzen, K. D., & Nydam, T. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-40908-5_16 · Cited by 1
Physical Wtness, fatigue, and quality of life after liver transplantation
van Ginneken, T. J., van den Berg-Emons, R. J. G., Geert Kazemier, M., Metselaar, H. J., Tilanus, H. W., & Stam, H. J. (2007)
Ladak, S. S. J. (2015) · TSpace (University of Toronto) · Cited by 2
Cagnolati, D., Souza, M. E. J., Silva, O. D. C. E., Jr, S., & Preto-SP, R. (2011)
Comparison of Motor Abilities of Young Children in Poland in the Years 1996 and 2006
Drohomirecka, A., Еider, J., Kotarska, K., Sygit, K., & Sygit, M. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Extracorporeal Liver Support Therapies for Children
Schaefer, B., Schmitt, C. P., & Basu, R. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-66861-7_46
A Cost-Effectiveness Decision Analysis of Living Donor Liver Transplantation
Northup, P. G. (2005) · doi:10.18130/v3239c
Transplantation for autoimmune liver diseases
Neuberger, J. (2007) · Springer eBooks · doi:10.1007/1-4020-2914-4_23
Trauner, M., & Boyer, J. L. (2000) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200005000-00006 · Cited by 1
Khakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
Disease Recurrence After Liver Transplantation
Berenguer, M., & Tejedor, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-07072-2_28
AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update
Aghemo, A., Calvaruso, V., Carbone, M., Cazzagon, N., Cristoferi, L., D’Amato, D., D’Ambrosio, R., Fianchi, F., Germani, G., Giannini, E. G., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.06.019 · Cited by 3
Metadata
- Authors
- Gross, C. R., Malinchoc, M., Kim, R. W., Evans, R. W., Wiesner, R. H., Petz, J. L., Crippin, J. S., Klintmalm, G. B., Levy, M. F., Ricci, P., Therneau, T. M., & Dickson, R. E.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- Baylor University Medical Center (US)
- University of Florida (US)
- Venue
- Hepatology
- Published
- 1999-02
- Volume
- 29
- Issue
- 2
- Pages
- 356-364
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2071987840
- Semantic Scholar
- dd59f3c16f82059eeb0e53343c22f61a3b6d6815
- Cited by
- 192
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6056 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 34238, R01DK034238)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver transplantation, quality of life, primary biliary cirrhosis, primary sclerosing cholangitis, cholestatic liver disease, end-stage liver disease, post-transplant outcomes, health status, clinical symptoms, physical function, social functioning, emotional functioning, health satisfaction, ascites, renal dysfunction
- MeSH terms
- Adult, Fatigue, Female, Health Status, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Pruritus, Quality of Life, Surveys and Questionnaires, Reoperation, Sleep Wake Disorders, Cholangitis, Sclerosing, Liver Transplantation, Karnofsky Performance Status
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.